Growing community of inventors

Rancho Santa Fe, CA, United States of America

Frank Tufaro

Average Co-Inventor Count = 4.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Frank TufaroCharles A Conrad (3 patents)Frank TufaroCandelaria Gomez-Manzano (3 patents)Frank TufaroJuan Fueyo-Margareto (3 patents)Frank TufaroW K Alfred Yung (2 patents)Frank TufaroFrederick Lang, Jr (2 patents)Frank TufaroAmy Heimberger (2 patents)Frank TufaroJuan Fueyo (4 patents)Frank TufaroHong Jiang (1 patent)Frank TufaroWk Alfred Yung (1 patent)Frank TufaroJoanna J Peterkin (1 patent)Frank TufaroCandeleria Manzano-Gomez (0 patent)Frank TufaroFred Lang (0 patent)Frank TufaroFrank Tufaro (4 patents)Charles A ConradCharles A Conrad (22 patents)Candelaria Gomez-ManzanoCandelaria Gomez-Manzano (9 patents)Juan Fueyo-MargaretoJuan Fueyo-Margareto (5 patents)W K Alfred YungW K Alfred Yung (6 patents)Frederick Lang, JrFrederick Lang, Jr (4 patents)Amy HeimbergerAmy Heimberger (4 patents)Juan FueyoJuan Fueyo (4 patents)Hong JiangHong Jiang (2 patents)Wk Alfred YungWk Alfred Yung (2 patents)Joanna J PeterkinJoanna J Peterkin (1 patent)Candeleria Manzano-GomezCandeleria Manzano-Gomez (0 patent)Fred LangFred Lang (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dnatrix, Inc. (4 from 5 patents)

2. University of Texas System (3 from 5,444 patents)


4 patents:

1. 11110137 - Combination therapy for treatment of brain cancers

2. 11090344 - Adenovirus and immunomodulator combination therapy

3. 11065285 - Biomarkers and combination therapies using oncolytic virus and immunomodulation

4. 10238698 - Biomarkers and combination therapies using oncolytic virus and immunomodulation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…